Bruce Kerwin, Ph.D.
VP of Drug Product Design
Dr. Bruce Kerwin is responsible for all aspects of Drug Product Design at Just including development of our high throughput biophysical characterization platform, formulation platform, and commercial drug product. Dr. Kerwin has worked in the biotechnology industry for more than 20 years and is a recognized expert in protein formulation and drug product development. In prior roles at Amgen he led numerous project teams developing novel solutions to formulation problems such as high viscosity, high concentration and protein aggregation. He contributed to numerous programs that successfully brought drug candidates through development with contributions to commercialized biopharmaceuticals such as Aranesp®, Vectibix®, Imlygic™ and Kineret®.
His work on large and small volume parenteral formulations included monoclonal antibodies, antibody drug conjugates, PEGylated proteins, glycosylated and non-glycosylated proteins and viruses. Bruce was also intimately involved with alternative drug delivery systems at Amgen such as slow release and nanoparticle formulations. He has over 50 research publications relating to protein science and formulation development, is an inventor on multiple patents and holds an adjunct appointment as an Associate Professor on the faculty of the School of Pharmaceutical Chemistry at the University of Kansas.